Please assess the completion status of the following clinical trial:

Trial Title: Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus Erythematosus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Eligible participants were premenopausal women with SLE~* Older than 18 years~* Attending the outpatient Rheumatology Clinic at three Mexico City community tertiary care hospitals~Exclusion Criteria:~* menopause~* diabetes~* thyroid dysfunction~* neurological~* hepatic~* renal or liver disease~* personal history of high blood pressure~* CHD (coronary heart disease)~* cerebrovascular events~* chronic or acute infections~* malignancy~* nor history of chronic drugs or alcohol abuse~* smoking~* pregnancy or breast-feeding~* intake of hormones or lipid-regulating drugs

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- sugar pill (Type: PLACEBO_COMPARATOR): tablet similar to comparator
- pioglitazone (Type: ACTIVE_COMPARATOR): 30 mg tablets QD (taken once daily)

Based on this trial design, predict the completion outcome and termination type (if applicable).